Citrus monstruosa discrimination among several citrus species by multivariate analysis of volatiles: A metabolomic approach

The origin and taxonomy of Citrus monstruosa (Rutaceae) are currently unknown and thus a nontargeted metabolomic analysis on the flavedo volatiles was performed. Headspace solid-phase micro extraction coupled with gas chromatography analysis was applied to eight Citrus spp. including Citrus monstruosa, and the chemical composition of the volatile organic compounds (VOC) was analyzed to give a chemical comparison between different Citrus species. Forty-four metabolites were detected across the species: several monoterpenes were found in all Citrus spp. and among them limonene comes first in all Citrus spp. ranging from 96.7 to 66.7%. Conversely, some molecules were found to be specific for only a few of the samples. The classical univariate evaluation of the VOC data is unlikely to give objective data for the cultivar classification; a multivariate approach, principal component analysis, is an easy to use, powerful tool. Therefore, a chemometric comparison between chromatographic data of all Citrus spp. was performed with the aim of understanding the role of VOC in the discrimination of the eight studied cultivar

Mortality after surgery in Europe: a 7 day cohort study

Background: Clinical outcomes after major surgery are poorly described at the national level. Evidence of heterogeneity between hospitals and health-care systems suggests potential to improve care for patients but this potential remains unconfirmed. The European Surgical Outcomes Study was an international study designed to assess outcomes after non-cardiac surgery in Europe.Methods: We did this 7 day cohort study between April 4 and April 11, 2011. We collected data describing consecutive patients aged 16 years and older undergoing inpatient non-cardiac surgery in 498 hospitals across 28 European nations. Patients were followed up for a maximum of 60 days. The primary endpoint was in-hospital mortality. Secondary outcome measures were duration of hospital stay and admission to critical care. We used χ² and Fisher’s exact tests to compare categorical variables and the t test or the Mann-Whitney U test to compare continuous variables. Significance was set at p<0·05. We constructed multilevel logistic regression models to adjust for the differences in mortality rates between countries.Findings: We included 46 539 patients, of whom 1855 (4%) died before hospital discharge. 3599 (8%) patients were admitted to critical care after surgery with a median length of stay of 1·2 days (IQR 0·9–3·6). 1358 (73%) patients who died were not admitted to critical care at any stage after surgery. Crude mortality rates varied widely between countries (from 1·2% [95% CI 0·0–3·0] for Iceland to 21·5% [16·9–26·2] for Latvia). After adjustment for confounding variables, important differences remained between countries when compared with the UK, the country with the largest dataset (OR range from 0·44 [95% CI 0·19 1·05; p=0·06] for Finland to 6·92 [2·37–20·27; p=0·0004] for Poland).Interpretation: The mortality rate for patients undergoing inpatient non-cardiac surgery was higher than anticipated. Variations in mortality between countries suggest the need for national and international strategies to improve care for this group of patients.Funding: European Society of Intensive Care Medicine, European Society of Anaesthesiology